查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1649405

大容量肠外药物市场 - 预测至 2025 年至 2030 年

Large Volume Parenteral Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 137 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

大容量肠外药物市场预计将以 5.05% 的复合年增长率成长，从 2025 年的 123.85 亿美元达到 2030 年的 158.43 亿美元。

大容量肠外注射剂 (LVP) 是静脉注射的体积大于 100 毫升（最多 2000 毫升）的无菌溶液。这些溶液（例如氯化钠、葡萄糖、林格氏溶液、乳酸林格氏溶液）对于补水、电解质平衡、营养支持和快速药物给药至关重要，尤其是在外科和慢性病护理环境中。

市场驱动因素

  • 慢性病负担：全球需要住院治疗的疾病（如癌症、糖尿病、肾臟病）的盛行率正在增加。
  • 外科手术数量不断增加：市场扩张是由外科手术数量不断增加所推动的，其中 LVP 对于麻醉、补液和术后护理至关重要。
  • 药物传递的进展：LVP 可以实现高效持续给药，例如用于癌症疼痛管理的氢可酮，满足单剂量治疗和简化治疗通讯协定的需求。

地理见解

  • 北美引领市场，得益于强大的医疗保健基础设施和高发生率的慢性疼痛疾病。例如，美国癌症协会预测，2024 年美国将有 2,001,140 例新癌症病例和 611,720 例死亡病例，支持了 LVP 在疼痛管理方面的需求。
  • 。该地区不断增长的手术量和对先进液体替代疗法的重视进一步巩固了其地位。

这一增长反映了 LVP 在现代医疗保健中发挥的重要作用，以精确性和扩充性满足了急性护理需求和长期治疗需求。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 适合广泛用户：对于新兴企业、科学研究机构、顾问公司、中小企业和大型企业来说都是有益且具成本效益的。

它有什么用途？

产业与市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的历史资料与预测
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争定位、策略和市场占有率分析
  • 各细分市场及各地区（包括国家）的收益成长及预测分析
  • 公司概况（尤其是关键发展）

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

5. 大剂量肠外药物市场（以数量计算）

  • 介绍
  • 100ml-250ml
  • 250ml-500ml
  • 500毫升以上

第六章 大容量肠外药物市场（依应用）

  • 介绍
  • 纠正电解质和液体失衡
  • 营养
  • 用于给药其他药物的车辆

7. 大剂量注射用药物市场（依包装类型）

  • 介绍
  • 纠正电解质和液体失衡
  • 营养
  • 用于给药其他药物的车辆

8. 大宗肠外药物市场（按地区）

  • 介绍
  • 北美洲
    • 按数量
    • 按应用
    • 按包装容器
    • 按国家
  • 南美洲
    • 按数量
    • 按应用
    • 按包装容器
    • 按国家
  • 欧洲
    • 按数量
    • 按应用
    • 按包装容器
    • 按国家
  • 中东和非洲
    • 按数量
    • 按应用
    • 按包装容器
    • 按国家
  • 亚太地区
    • 按数量
    • 按应用
    • 按包装容器
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Fresenius Kabi AG
  • Albert David Ltd.
  • Otsuka Holdings Co., Ltd.
  • Grifols SA
  • B. Braun Melsungen AG
  • BML Parenteral Drugs
  • Akums Drugs & Pharmaceuticals Ltd.
  • DJ Labs
  • Parenteral Drugs（India）Limited
  • BKRS Pharma Pvt. Ltd.
  • Pfizer.
  • Baxter.
  • August Services
  • INCOG BioPharma Services
  • Simtra BioPharma Solutions
简介目录
Product Code: KSI061613637

The large volume parenteral market is expected to grow at a CAGR of 5.05%, reaching a market size of US$15.843 billion in 2030 from US$12.385 billion in 2025.

Large volume parenterals (LVPs) are sterile solutions administered intravenously in volumes exceeding 100 mL (ranging up to 2000 mL). These solutions-such as sodium chloride, dextrose, Ringer's, and lactated Ringer's-are critical for fluid replacement, electrolyte balance, nutrition, and rapid medication delivery, particularly in surgical and chronic care settings.

Market Drivers

  • Chronic Disease Burden: Rising global prevalence of conditions requiring hospitalization (e.g., cancer, diabetes, renal disorders) fuels demand for LVPs in fluid and nutrient therapy.
  • Surgical Volume Growth: Increasing surgical procedures, where LVPs are essential for anesthesia, hydration, and post-operative care, drive market expansion.
  • Advancements in Drug Delivery: LVPs enable efficient, continuous administration of medications like morphine for cancer pain management, aligning with the demand for single-dose therapies and streamlined treatment protocols.

Geographical Insights

  • North America leads the market, supported by robust healthcare infrastructure and high rates of chronic pain conditions. For example, the American Cancer Society projects 2,001,140 new cancer cases and 611,720 deaths in the U.S. in 2024, underscoring the need for LVPs in pain management.
  • The region's growing surgical volumes and emphasis on advanced fluid replacement therapies further solidify its dominance.

This growth reflects LVPs' pivotal role in modern healthcare, bridging acute care needs with long-term therapeutic demands through precision and scalability.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The large volume parenteral market is segmented and analyzed as follows:

By Volume

  • 100 ml - 250 ml
  • 250 ml - 500 ml
  • Above 500 ml

By Application

  • Correction of electrolyte & fluid balance disturbances
  • Nutrition
  • Vehicle for administering other drugs

By Packaging Container

  • Glass Bottle
  • Plastic Bags

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. LARGE VOLUME PARENTERAL MARKET BY VOLUME

  • 5.1. Introduction
  • 5.2. 100 ml - 250 ml
  • 5.3. 250 ml - 500 ml
  • 5.4. Above 500 ml

6. LARGE VOLUME PARENTERAL MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Correction of electrolyte & fluid balance disturbances
  • 6.3. Nutrition
  • 6.4. Vehicle for administering other drugs

7. LARGE VOLUME PARENTERAL MARKET BY PACKAGING CONTAINER

  • 7.1. Introduction
  • 7.2. Correction of electrolyte & fluid balance disturbances
  • 7.3. Nutrition
  • 7.4. Vehicle for administering other drugs

8. LARGE VOLUME PARENTERAL MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Volume
    • 8.2.2. By Application
    • 8.2.3. By Packaging Container
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Volume
    • 8.3.2. By Application
    • 8.3.3. By Packaging Container
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Volume
    • 8.4.2. By Application
    • 8.4.3. By Packaging Container
    • 8.4.4. By Country
      • 8.4.4.1. UK
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Volume
    • 8.5.2. By Application
    • 8.5.3. By Packaging Container
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Israel
      • 8.5.4.3. Saudi Arabia
      • 8.5.4.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Volume
    • 8.6.2. By Application
    • 8.6.3. By Packaging Container
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Fresenius Kabi AG
  • 10.2. Albert David Ltd.
  • 10.3. Otsuka Holdings Co., Ltd.
  • 10.4. Grifols S.A.
  • 10.5. B. Braun Melsungen AG
  • 10.6. BML Parenteral Drugs
  • 10.7. Akums Drugs & Pharmaceuticals Ltd.
  • 10.8. DJ Labs
  • 10.9. Parenteral Drugs (India) Limited
  • 10.10. BKRS Pharma Pvt. Ltd.
  • 10.11. Pfizer.
  • 10.12. Baxter.
  • 10.13. August Services
  • 10.14. INCOG BioPharma Services
  • 10.15. Simtra BioPharma Solutions